skip to content

Iron(ii) sulfate, Extended time release vitamin c, KENDURAL C extended-release tablets

Teofarma srl

Sale price £34.95 Regular price £50.00

Tax included. Shipping calculated at checkout.

KENDURAL C extended-release tablets, Iron(ii) sulfate, Extended time release vitamin c

Pack size:50 pieces Dosage form:Extended-Release Tablets


Active Iron(ii) sulfate, Extended time release vitamin c, KENDURAL C extended-release tablets ingredient:

 iron (II) sulfate

For the treatment of iron deficiency anemia and iron deficiency conditions.

Active Iron(ii) sulfate, Extended time release vitamin c, KENDURAL C extended-release tablets ingredients

  • 329.7 mg iron (II) sulfate, dried
  • 500 mg ascorbic acid


  • Magnesium stearate
  • Hypromelosis
  • Ethyl cellulose
  • Ponceau 4R
  • Cellulose, microcrystalline
  • Povidone K29-32
  • Poly(methacrylate-co-methyl methacrylate, 60:40)
  • Cornstarch
  • Lactose-1-water
  • Macrogol 400
  • Macrogol 8000
  • Titanium dioxide
  • talc


Iron(ii) sulfate, Extended time release vitamin c, KENDURAL C extended-release tablets Indication :


  • The medicine is an antianemic and is used to treat iron deficiency anemia and iron deficiency states.
Dosage :
  • Always take the medicine exactly as directed. Please ask your doctor or pharmacist if you are not sure.
  • Unless otherwise prescribed by the doctor, the usual dose is:
    • Take 1 modified-release tablet daily on an empty stomach before breakfast.
    • Due to the size of the tablets, the product is not suitable for children under 8 years of age.


  • Duration of application
    • The duration of the usage will be decided by the medicating doctor.
    • Please talk to your doctor or pharmacist if you have the impression that the effect of the medicine is too strong or too weak.


  • If you have taken more than you should
    • Acute iron overdose can cause nausea and vomiting, and in severe cases, circulatory collapse and death.
    • In case of overdose, the stomach should be emptied by induced vomiting or gastric lavage. If the patient has already vomited blood several times, the use of vomiting root should not be used. The vomit should be examined for tablet residue. If not all swallowed tablets have been vomited, gastric lavage with physiological saline solution with the addition of reducing laxatives should be considered.
    • Hemodialysis is of little value in the treatment of iron intoxication.
    • Supportive measures such as control of breathing and circulation, if necessary administration of plasma expanders and oxygen, should be used as necessary.


  • If you forget to take it
    • Do not take a double dose if you forget to take the previous dose.


  • If you have any further questions about using the medicine, ask your doctor or pharmacist.
Way :
  • The tablet should be swallowed whole with sufficient water. Iron absorption is inhibited by ingredients in eggs, milk, bran (phytate), coffee and black tea (tannin). Therefore, it should be taken at least two hours apart from a meal containing one of these foods.
Side effects :
  • Like all medicines, the preparation can have side effects, although not everyone gets them.
  • When evaluating side effects, the following frequency information is used:
    • Very common: more than 1 patient in 10
    • Common: 1 to 10 treated in 100
    • Uncommon: 1 to 10 people treated in 1,000
    • Rare: 1 to 10 people treated in 10,000
    • Very rare: less than 1 person treated in 10,000
    • Not known: Frequency cannot be estimated from the available data.
  • Possible side effects:
    • Occasionally, mild gastrointestinal symptoms such as nausea, vomiting, upper abdominal discomfort and diarrhea may occur. In rare cases, allergic reactions (e.g. skin redness, shock) may occur.
    • Stone formation from oxalates has been reported following ingestion of high doses of ascorbic acid.
  • Please inform your doctor or pharmacist if any of the side effects listed seriously affects you or if you notice side effects that are not listed.
Interactions :
  • When taking the product with other medicines:
    • Please inform your doctor or pharmacist if you are taking or have recently taken any other medicines, even if they are non-prescription medicines.
    • Due to mutual inhibition of absorption (uptake), simultaneous administration of the drug and a tetracycline antibiotic should be avoided.
    • Simultaneous administration of the preparation and antacids (with aluminum, magnesium or calcium ions) causes reduced iron absorption. The same applies to a combination with cholestyramine.
    • Levodopa, penicillamine, thyroxine, bisphosphonates and quinolone derivatives (e.g. ciprofloxacin, norfloxacin, ofloxacin) should be taken at least two hours apart from the drug.
    • Additionally administered ascorbic acid (vitamin C) increases iron absorption.
    • Taking it at the same time as chloramphenicol can delay the onset of effect of iron therapy.
    • When anticoagulants and ascorbic acid are administered at the same time, the Quick value is reduced.
    • Taking iron salts and non-steroidal anti-inflammatory drugs at the same time can increase the irritating effects of iron on the mucous membranes of the gastrointestinal tract.
  • When taking the medicine with food and drink
    • Iron absorption is inhibited by ingredients in eggs, milk, bran (phytate), coffee and black tea (tannin).
    • The preparation allows the entire therapeutic daily dose to be taken in the morning on an empty stomach in a single modified-release tablet. This avoids the negative influences of food components on iron absorption.
Contraindications :
  • The medicine must not be taken
    • if you are hypersensitive (allergic) to dried iron (II) sulfate, ascorbic acid or any of the other ingredients of the preparation,
    • in cases of iron accumulation (hemochromatosis, chronic hemolysis),
    • in iron utilization disorders (sideroachrestic anemias, lead anemias, thalassemias),
    • for any type of intestinal obstruction,
    • if you have kidney stones,
    • with vitamin B 12 deficiency anemia,
    • of patients receiving repeated blood transfusions or parenteral iron.
  • What should be taken into account with children?
    • Poisoning following the unintentional ingestion of preparations containing iron is a particularly common cause of fatal cases of poisoning in children under 6 years of age. Like any other medicine, the preparation should be kept out of the reach of children.
Pregnancy and breastfeeding :
  • Before taking/using any medicines, ask your doctor or pharmacist for advice.
  • pregnancy
    • If you are pregnant, you should only take this medicine if your doctor has diagnosed you with iron deficiency.
  • lactation
    • If you are breast-feeding, you should only take the product as directed by your doctor.
    • Ascorbic acid passes into breast milk.
Patient information :
  • Particular caution is required when taking the drug
    • if anemia is present. The cause should be investigated and therapy tailored accordingly.
    • Any darkening of the stool that may occur during treatment is harmless. The benzidine sample can be false positive during treatment; due to the ascorbic acid content in the preparation, the Haemocult test can show a false negative result.
    • Ascorbic acid in urine can lead to incorrect values ​​when determining urine sugar.
    • To avoid the risk of possible iron overdose, special caution should be exercised if dietary or other iron salt supplements are used.
    • In the case of pre-existing inflammation or ulcers of the gastrointestinal mucosa, the benefits of treatment should be carefully weighed against the risk of worsening the gastrointestinal disease.


  • Ability to drive and use machines:
    • Taking the medicine has no harmful effects on your ability to drive, react or act in general, even when operating machines or when working without a secure footing.